Editors:
- Current perspectives on state-of-the-art therapies
- Contains chapters specific to angiogenesis and antiangiogenic treatment of many malignant diseases
Part of the book series: Cancer Drug Discovery and Development (CDD&D)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (31 chapters)
-
Front Matter
-
Basic Biology of Angiogenesis
-
Front Matter
-
-
Translational Research in Tumor Angiogenesis
-
Front Matter
-
About this book
Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge. Antiangiogenic Agents in Cancer Therapy, Second Edition provides a current, up-dated perspective on the state of the art of angiogenesis and therapy with a compendium of scientific findings and approaches to the study of angiogenesis in cancer. Leaders in the field present chapters on such topics as the environmental influences and the genetic and physiologic abnormalities that mediate angiogenesis and its role in the progression of malignant disease, working models of tumor angiogenesis, and the role of angiogenesis inhibition in the therapy of malignant disease in humans.
Comprehensive and cutting-edge, Antiangiogenic Agents in Cancer Therapy, Second Edition is an ideal, valuable guide to the most recent advances in the field, and a collection that will be useful for many years to come.
Reviews
From the reviews of the second edition:
"This is a second edition of a well-accepted text on angiogenesis and antiangiogenic agents, particularly on their use in cancer therapy. In addition to the editors, a large number of outstanding investigators have contributed to this book. … This edition is highly recommended to all of those involved in research or the clinical practice of oncology." (Julian L. Ambrus and Clara M. Ambrus, The Journal of Medicine, March, 2008)
Editors and Affiliations
-
Genzyme Corporation, Framingham
Beverly A. Teicher
-
M. D. Anderson Cancer Center, The University of Texas, Houston
Lee M. Ellis
Bibliographic Information
Book Title: Antiangiogenic Agents in Cancer Therapy
Editors: Beverly A. Teicher, Lee M. Ellis
Series Title: Cancer Drug Discovery and Development
DOI: https://doi.org/10.1007/978-1-59745-184-0
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Humana Press 2008
Hardcover ISBN: 978-1-58829-870-6Published: 12 December 2007
Softcover ISBN: 978-1-4939-5628-9Published: 23 August 2016
eBook ISBN: 978-1-59745-184-0Published: 08 January 2008
Series ISSN: 2196-9906
Series E-ISSN: 2196-9914
Edition Number: 2
Number of Pages: XVIII, 559
Topics: Cancer Research, Oncology, Surgical Oncology, Pharmacology/Toxicology